Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate)
Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
Multi-center, prospective randomized dosing and safety research study. A maximum of 150 men
will be enrolled in the study. Qualifying patients will receive one of three possible doses
of the study drug. Symptoms will be evaluated before treatment, and then 1-week, 1-month,
3-months, and 6-months following treatment.